Commercialized cetylpyridinium chloride ( CPC ) mouthrinses were compared for antimicrobial substantivity/bioavailability in an in vitro disk retention assay ( DRA ) and clinical antimicrobial activity in vivo in the plaque glycolysis and regrowth method ( PGRM ) .